20 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
Claritev Corporation (CTEV) operates in the HEALTH INFORMATION SERVICES industry and is headquartered in McLean, United States with about 3,000 employees. Its market capitalization is roughly $407 million. In the fiscal year ended 2025-12-31, CTEV reported $965M in revenue and ($284M) in net income.
Claritev Corporation, together with its subsidiaries, provides data analytics and technology-enabled end-to-end cost management, payment, and revenue integrity solutions to the healthcare industry in the United States.
Interactive charts & full statements → Open the CTEV valuation workbench →
| Income statement | TTM → 2026-06-30 | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | $995M | $965M | $931M | $962M | $1.1B | $1.1B | $938M | $983M | $1.0B |
| Gross Profit | $440M | $267M | $691M | $726M | $876M | $942M | $619M | $833M | $891M |
| Gross Margin % | 44.3% | 27.6% | 74.3% | 75.5% | 81.1% | 84.3% | 66.0% | 84.8% | 85.6% |
| Operating Income (EBIT) | $49M | $45M | ($1.4B) | $162M | ($363M) | $386M | ($132M) | $368M | $428M |
| Operating Margin % | 4.9% | 4.7% | -149.3% | 16.9% | -33.6% | 34.5% | -14.1% | 37.5% | 41.1% |
| Net Income | ($283M) | ($284M) | ($1.6B) | ($92M) | ($573M) | $102M | ($521M) | $10M | $36M |
| Net Margin % | -28.5% | -29.4% | -176.8% | -9.5% | -53.1% | 9.1% | -55.5% | 1.0% | 3.5% |
| EBITDA | $591M | $475M | ($1.0B) | $652M | $158M | $815M | $192M | $786M | $814M |
| Earnings Per Share (EPS) | $-17.03 | $-17.30 | $-101.92 | $-5.69 | $-35.87 | $6.27 | $-44.23 | $0.35 | $1.32 |
| Shares Outstanding (M) | 17M | 16M | 16M | 16M | 16M | 16M | 12M | 28M | 28M |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly income statement | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | $257M | $245M | $247M | $246M | $242M | $231M | $232M | $230M |
| Gross Profit | $23M | $65M | $169M | $184M | $181M | $171M | $175M | $170M |
| Gross Margin % | 9.1% | 26.4% | 68.3% | 74.8% | 74.8% | 73.9% | 75.4% | 73.6% |
| Operating Income (EBIT) | $23M | $7M | $9M | $10M | $17M | $10M | ($41M) | ($338M) |
| Operating Margin % | 9.1% | 2.7% | 3.5% | 4.1% | 6.9% | 4.2% | -17.8% | -146.7% |
| Net Income | ($59M) | ($74M) | ($81M) | ($70M) | ($63M) | ($71M) | ($138M) | ($391M) |
| Net Margin % | -23.0% | -30.1% | -32.7% | -28.4% | -25.9% | -30.8% | -59.4% | -169.8% |
| EBITDA | $202M | $117M | $105M | $167M | $129M | $113M | $5M | ($227M) |
| Earnings Per Share (EPS) | $-3.49 | $-4.41 | $-4.90 | $-4.23 | $-3.81 | $-4.38 | $-8.54 | $-24.25 |
| Shares Outstanding (M) | 17M | 17M | 16M | 16M | 16M | 16M | 16M | 16M |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Cash flow | TTM → 2026-06-30 | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
|---|---|---|---|---|---|---|---|---|---|
| Cash from Operations (CFO) | $133M | $117M | $108M | $172M | $372M | $405M | $377M | $284M | $292M |
| Capital Expenditures (CapEx) | $151M | $130M | $118M | $109M | $90M | $85M | $71M | $66M | $64M |
| Free Cash Flow (FCF) | ($18M) | ($12M) | ($11M) | $63M | $283M | $320M | $307M | $218M | $229M |
| FCF Margin % | -1.8% | -1.3% | -1.1% | 6.5% | 26.2% | 28.6% | 32.7% | 22.2% | 22.0% |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly cash flow | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|---|---|---|---|
| Cash from Operations (CFO) | $93M | ($46M) | $66M | $20M | $61M | ($30M) | ($34M) | $73M |
| Capital Expenditures (CapEx) | $38M | $47M | $30M | $36M | $25M | $39M | $30M | $32M |
| Free Cash Flow (FCF) | $55M | ($93M) | $36M | ($16M) | $37M | ($69M) | ($64M) | $41M |
| FCF Margin % | 21.2% | -37.8% | 14.8% | -6.7% | 15.2% | -29.8% | -27.8% | 17.8% |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2026-06-30 | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $4.8B | $4.9B | $5.2B | $7.0B | $7.4B | $8.2B | $8.3B | $8.4B |
| Cash & Cash Equivalents | $14M | $17M | $17M | $72M | $334M | $185M | $127M | $22M |
| Total Liabilities | $5.1B | $5.1B | $5.1B | $5.3B | $5.6B | $5.9B | $5.7B | $6.4B |
| Total Debt (Short + Long-Term) | $4.7B | $4.6B | $4.5B | $4.6B | $4.8B | $4.9B | $6M | $10M |
| Total Shareholders' Equity | ($295M) | ($174M) | $84M | $1.7B | $1.8B | $2.3B | $2.6B | $2.0B |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive CTEV viewer.
About TickerBase · Data methodology & sources · Privacy · Terms